on 27 Mar 2023
Last Applicant/ Owned by
No.218 Xinghu Street, Suzhou IndustrialP
CN
Serial Number
79329638 filed on 01st Nov 2021
Registration Number
N/A
Correspondent Address
ZHI DONG
Filing Basis
No Filing Basis
Disclaimer
NO DATA
The mark consists of the stylized wording "ABOGENBIO". Technological research in the field of medical research; quality control for others; product quality testing; cancer research for medical purposes; pharmaceutical drug development services; pharmaceutical product evaluation, namely, drug evaluation; pharmaceutical research services; medical research; development of pharmaceutical preparationsRead More
pharmaceutical preparations for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; chemico-pharmaceutical preparations for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; drugs being pharmaceutical preparations for medical purposes for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; cultures of microorganisms for medical or veterinary use; biological preparations for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases for medical purposes; medicines for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases for human purposes; chemical preparations for medical purposes, namely, for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; crude drug being homeopathic pharmaceuticals for the treatment of viral disease, lipid particle for nucleotide drug delivery purpose and nucleotide; biochemical medicines for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; dietetic substances being foods and beverages adapted for medical use
Technological research in the field of medical research; quality control for others; product quality testing; cancer research for medical purposes; pharmaceutical drug development services; pharmaceutical product evaluation, namely, drug evaluation; pharmaceutical research services; medical research; development of pharmaceutical preparations and pharmaceuticals
No 79329638
No Service Mark
No 20700.0331US
No
No
No
No
No
No
No
No
The mark consists of the stylized wording "ABOGENBIO".
| Status Date | Action Taken |
|---|---|
| 18th Jun 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 31st May 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 31st May 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 19th Apr 2023 | REFUSAL PROCESSED BY IB |
| 27th Mar 2023 | OPPOSITION INSTITUTED NO. 999999 |
| 22nd Mar 2023 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
| 22nd Mar 2023 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
| 15th Dec 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 22nd Nov 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 22nd Nov 2022 | PUBLISHED FOR OPPOSITION |
